Kyoungyun Jeong
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kyoungyun Jeong has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Do Joong Park
Department of Surgery, Seoul National University Hospital, Seoul, Korea
2 shared publications - Hyuk-Joon Lee
Department of Surgery, Seoul National University Hospital, Seoul, Korea
2 shared publications - Seong-Ho Kong
Division of Gastrointestinal Surgery, Department of Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
2 shared publications - André Pèlegrin
IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Institut régional du Cancer de Montpellier, Montpellier, F-34298, France
1 shared publication Annie Eunhee Koo
Cancer Research Institute, College of Medicine, Seoul National University, 101 Daehak-ro, Jongro-gu, Seoul 03080, Republic of Korea
1 shared publicationBérénice Framery
SurgiMAb, 10 Parc Club du Millénaire, 1025 avenue Henri Becquerel, 34000 Montpellier, France
1 shared publication
Latest Publications
- Open Access
- 22 December 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (2) , 404-417
Association of Macrophage Accumulation and Polarization in Patients with Obesity and Diabetes with Diabetic Remission After Bariatric Surgery
Introduction: Chronically elevated proinflammatory cytokines and following low-grade tissue inflammation in adipose tissue of patients with obesity induced by M1 macrophages may increase insulin resistance and type 2 diabetes. However, actual macrophage distribution in patients with obesity and diabetes has not clearly confirmed yet. We aimed to reveal the relationship of macrophage accumulation and polarization in visceral fat to patients’ obesity and diabetes status, and to validate the role of preoperative M1 macrophage polarization as a predictor for diabetic remission after bariatric surgery. Methods: This single-center prospective observational study enrolled 80 patients. Experimental and control 1 group included patients with BMI≧30, with/without type 2 diabetes. Control 2 and control 3 group included patients with stage I gastric cancer and BMIp p p <0.001). M1 dominance was observed in patients achieving complete remission postoperatively or with ABCD score≧7 preoperatively. Conclusion: Patients with obesity and diabetes (experimental) demonstrated macrophage accumulation, M1 polarization, and proinflammatory circumstance. Preoperative M1 dominance with proinflammatory circumstances may be associated with better diabetic remission after bariatric surgery.
- 22 December 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (2) , 404-417
Open AccessAssociation of Macrophage Accumulation and Polarization in Patients with Obesity and Diabetes with Diabetic Remission After Bariatric Surgery
Introduction: Chronically elevated proinflammatory cytokines and following low-grade tissue inflammation in adipose tissue of patients with obesity induced by M1 macrophages may increase insulin resistance and type 2 diabetes. However, actual macrophage distribution in patients with obesity and diabetes has not clearly confirmed yet. We aimed to reveal the relationship of macrophage accumulation and polarization in visceral fat to patients’ obesity and diabetes status, and to validate the role of preoperative M1 macrophage polarization as a predictor for diabetic remission after bariatric surgery. Methods: This single-center prospective observational study enrolled 80 patients. Experimental and control 1 group included patients with BMI≧30, with/without type 2 diabetes. Control 2 and control 3 group included patients with stage I gastric cancer and BMIp p p <0.001). M1 dominance was observed in patients achieving complete remission postoperatively or with ABCD score≧7 preoperatively. Conclusion: Patients with obesity and diabetes (experimental) demonstrated macrophage accumulation, M1 polarization, and proinflammatory circumstance. Preoperative M1 dominance with proinflammatory circumstances may be associated with better diabetic remission after bariatric surgery.
- Open Access
Feasibility of Anti-CEA Dye Conjugate for Cancer-Specific Imaging in Gastric Cancer Cell Lines and Mouse Xenograft Models
Purpose: Near-infrared fluorescence-guided surgery (FGS) using cancer-specific tracers is promising for tailored gastric cancer (GC) surgery. Carcinoembryonic antigen (CEA) is a potential target due to its high expression in various digestive cancers, including GC. Materials and Methods: SGM-101, a chimeric anti-CEA monoclonal antibody conjugated with the near-infrared dye BM-104, was evaluated in GC. CEA expression was identified in GC cell lines at the mRNA and protein levels. Xenograft models (MKN-45, SNU-16, SNU-668, 85As2mLuc) were established in mice and injected with SGM-101 or PBS. Biodistribution was monitored using in vivo fluorescence imaging. Tumors were further analyzed by immunofluorescence. In a peritoneal carcinomatosis model, 85As2mLuc cells were injected intraperitoneally, and tumors were evaluated by bioluminescence and fluorescence and histology. Results: MKN-45, SNU-16, and 85As2mLuc were CEA-positive, while SNU-668 was CEA-negative. Flow cytometry confirmed CEA expression: MKN-45 (98%), SNU-16 (85.6%), SNU-668 (6.42%) and 85As2mLuc (78.4%). SGM-101 selectively targeted CEA-expressing tumors, with fluorescence peaking at 48 h, and immunofluorescence verified localization in tumor cells. In the peritoneal models, SGM-101 enabled precise detection of CEA-positive tumors. Conclusions: This study provides the first evidence for the feasibility of SGM-101 in gastric cancer, demonstrating its novelty and translational potential as a cancer-specific imaging agent for fluorescence-guided surgery.
Open AccessFeasibility of Anti-CEA Dye Conjugate for Cancer-Specific Imaging in Gastric Cancer Cell Lines and Mouse Xenograft Models
Purpose: Near-infrared fluorescence-guided surgery (FGS) using cancer-specific tracers is promising for tailored gastric cancer (GC) surgery. Carcinoembryonic antigen (CEA) is a potential target due to its high expression in various digestive cancers, including GC. Materials and Methods: SGM-101, a chimeric anti-CEA monoclonal antibody conjugated with the near-infrared dye BM-104, was evaluated in GC. CEA expression was identified in GC cell lines at the mRNA and protein levels. Xenograft models (MKN-45, SNU-16, SNU-668, 85As2mLuc) were established in mice and injected with SGM-101 or PBS. Biodistribution was monitored using in vivo fluorescence imaging. Tumors were further analyzed by immunofluorescence. In a peritoneal carcinomatosis model, 85As2mLuc cells were injected intraperitoneally, and tumors were evaluated by bioluminescence and fluorescence and histology. Results: MKN-45, SNU-16, and 85As2mLuc were CEA-positive, while SNU-668 was CEA-negative. Flow cytometry confirmed CEA expression: MKN-45 (98%), SNU-16 (85.6%), SNU-668 (6.42%) and 85As2mLuc (78.4%). SGM-101 selectively targeted CEA-expressing tumors, with fluorescence peaking at 48 h, and immunofluorescence verified localization in tumor cells. In the peritoneal models, SGM-101 enabled precise detection of CEA-positive tumors. Conclusions: This study provides the first evidence for the feasibility of SGM-101 in gastric cancer, demonstrating its novelty and translational potential as a cancer-specific imaging agent for fluorescence-guided surgery.